欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1205/001
药品名称Metotrexat Accord
活性成分
    • Methotrexate 25.0 mg/ml
剂型Solution for injection
上市许可持有人Accord Healthcare B.V. Netherlands
参考成员国 - 产品名称Sweden (SE)
Metotrexat Accord
互认成员国 - 产品名称
    • Germany (DE)
      Methotrexat Accord 25 mg/ml Injektionslösung
    • Belgium (BE)
      Methotrexaat Accord Healthcare 25 mg/ml oplossing voor injectie
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Methotrexat Accord 25 mg/ml Injektionslösung
    • Portugal (PT)
    • Cyprus (CY)
      METHOTREXATE SOLUTION FOR INJECTION
    • Czechia (CZ)
      Methotrexat Accord 25 mg/ml injekční roztok
    • Finland (FI)
    • Spain (ES)
    • France (FR)
    • Denmark (DK)
    • Lithuania (LT)
      Methotrexate Accord 25 mg/ ml injekcinis tirpalas
    • Norway (NO)
    • Estonia (EE)
      METHOTREXATE ACCORD
    • Italy (IT)
许可日期2012/05/21
最近更新日期2024/11/26
药物ATC编码
    • L01BA01 methotrexate
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase